U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Davoceticept
INN   USAN  
Official Name English
1-107-CD80 antigen [18-tyrosine,26-glutamic acid,35-aspartic acid,47-leucine,68-methionine,71-glycine,90-glycine] (human) fusion protein with peptide linker (GSGGGGS) fusion protein with immunoglobulin G1 [119-serine,133-alanine,134-glutamic acid,136-ala
Common Name English
Davoceticept [WHO-DD]
Common Name English
davoceticept [INN]
Common Name English
fragment (1-107) of human T-lymphocyte activation antigen CD80 (CTLA-4 (cytotoxic T-lymphocyte antigen 4) counterreceptor B7.1) variant (H18>Y, A26>E, E35>D, M47>L, V68>M, A71>G, D90>G) fused, via peptidyl linker 108GSGGGGS114 to human immunoglobulin G1
Common Name English
ALPN-202
Code English
DAVOCETICEPT [USAN]
Common Name English
ALPN202
Code English
Code System Code Type Description
CAS
2307144-64-3
Created by admin on Sat Dec 16 14:54:07 GMT 2023 , Edited by admin on Sat Dec 16 14:54:07 GMT 2023
PRIMARY
NCI_THESAURUS
C174515
Created by admin on Sat Dec 16 14:54:07 GMT 2023 , Edited by admin on Sat Dec 16 14:54:07 GMT 2023
PRIMARY
USAN
KL-165
Created by admin on Sat Dec 16 14:54:07 GMT 2023 , Edited by admin on Sat Dec 16 14:54:07 GMT 2023
PRIMARY
FDA UNII
DE9GN7CD21
Created by admin on Sat Dec 16 14:54:07 GMT 2023 , Edited by admin on Sat Dec 16 14:54:07 GMT 2023
PRIMARY
INN
11827
Created by admin on Sat Dec 16 14:54:07 GMT 2023 , Edited by admin on Sat Dec 16 14:54:07 GMT 2023
PRIMARY
ACTIVE MOIETY
Davoceticept
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966